GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
8CX3 | Q13421 | Crystal structure of full-length mesothelin | |
8CXI | A0A142DS37 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | Q9H9E1 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | A0A1S6LXE0 | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXI | 8CXI | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
8CXN | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
8CXN | 8CXN | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
8CY7 | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
8CY7 | 8CY7 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
8CYA | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
8CYA | 8CYA | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
8CYB | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
8CYB | 8CYB | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
8CYH | 8CYH | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
8CYH | Q13421 | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
8CZZ | A0A6C0ZY47 | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074 | |
8CZZ | 8CZZ | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074 | |
8D0O | Q9Y231 | Human alpha1,3-fucosyltransferase FUT9, heavy atom derivative | |
8D0P | Q9Y231 | Human FUT9, unliganded | |
8D0Q | Q9Y231 | Human FUT9 bound to GDP-CF3-Fucose and H-Type 2 | |
8D0R | Q9Y231 | Human FUT9 bound to GDP and H-Type 2 | |
8D0S | Q9Y231 | Human FUT9 bound to GDP and LNnT | |
8D0U | Q9Y231 | Human FUT9 bound to GDP | |
8D0W | Q9Y231 | Human FUT9 bound to H-Type 2 | |
8D0X | Q9Y231 | Human FUT9 bound to LNnT | |
8D0Y | 8D0Y | Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom | |
8D0Z | P0DTC2 | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
8D0Z | 8D0Z | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
8D21 | Q6WG00 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
8D21 | Q289M7 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
8D21 | 8D21 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
8D2S | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand bound conformation | |
8D2S | 8D2S | Zebrafish MFSD2A isoform B in inward open ligand bound conformation | |
8D2T | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand-free conformation | |
8D2T | 8D2T | Zebrafish MFSD2A isoform B in inward open ligand-free conformation | |
8D2U | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand 1A conformation | |
8D2U | 8D2U | Zebrafish MFSD2A isoform B in inward open ligand 1A conformation | |
8D2V | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand 1B conformation | |
8D2V | 8D2V | Zebrafish MFSD2A isoform B in inward open ligand 1B conformation | |
8D2W | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand 2B conformation | |
8D2W | 8D2W | Zebrafish MFSD2A isoform B in inward open ligand 2B conformation | |
8D2X | Q6DEJ6 | Zebrafish MFSD2A isoform B in inward open ligand 3C conformation | |
8D2X | 8D2X | Zebrafish MFSD2A isoform B in inward open ligand 3C conformation | |
8D3A | 8D3A | Crystal Structure of DH475 Fab in complex with Man9 | |
8D3C | P04275 | VWF tubule derived from monomeric D1-A1 | |
8D3D | P04275 | VWF tubule derived from dimeric D1-A1 | |
8D3T | A0A2K2AMS7 | Crystal structure of GalS1 from Populus trichocarpas | |
8D3Z | A0A2K2AMS7 | Crystal structure of GalS1 in complex with Manganese from Populus trichocarpas | |
8D43 | Q14697 | Cryo-EM structure of human Kidney Glucosidase II | |
8D43 | P14314 | Cryo-EM structure of human Kidney Glucosidase II |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024